LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells.

    Hachim, Mahmood Yaseen / Al Heialy, Saba / Hachim, Ibrahim Yaseen / Halwani, Rabih / Senok, Abiola C / Maghazachi, Azzam A / Hamid, Qutayba

    Frontiers in immunology

    2020  Volume 11, Page(s) 1372

    Abstract: ... therapeutic interventions. We analyzed publicly available transcriptomic datasets of SARS-CoV infected humans ... infected epithelial cells transcriptomic datasets. Comprehensive toxicogenomic analysis of the identified ... Despite ongoing research toward the development of a vaccine against SARS-CoV-2, such a vaccine will not ...

    Abstract Current guidelines for COVID-19 management recommend the utilization of various repurposed drugs. Despite ongoing research toward the development of a vaccine against SARS-CoV-2, such a vaccine will not be available in time to contribute to the containment of the ongoing pandemic. Therefore, there is an urgent need to develop a framework for the rapid identification of novel targets for diagnostic and therapeutic interventions. We analyzed publicly available transcriptomic datasets of SARS-CoV infected humans and mammals to identify consistent differentially expressed genes then validated in SARS-CoV-2 infected epithelial cells transcriptomic datasets. Comprehensive toxicogenomic analysis of the identified genes to identify possible interactions with clinically proven drugs was carried out. We identified IFITM3 as an early upregulated gene, and valproic acid was found to enhance its mRNA expression as well as induce its antiviral action. These findings indicate that analysis of publicly available transcriptomic and toxicogenomic data represents a rapid approach for the identification of novel targets and molecules that can modify the action of such targets during the early phases of emerging infections like COVID-19.
    MeSH term(s) 2',5'-Oligoadenylate Synthetase/genetics ; Animals ; Antiviral Agents/pharmacology ; Betacoronavirus/physiology ; COVID-19 ; Coronavirus Infections/genetics ; Coronavirus Infections/immunology ; Disease Models, Animal ; Ferrets ; Gene Expression Profiling ; Gene Expression Regulation/drug effects ; Humans ; Immunity, Innate ; Lung ; Macaca fascicularis ; Membrane Proteins/genetics ; Mice ; Myxovirus Resistance Proteins/genetics ; Pandemics ; Pneumonia, Viral/genetics ; Pneumonia, Viral/immunology ; RNA-Binding Proteins/genetics ; SARS-CoV-2 ; Species Specificity ; Up-Regulation/drug effects ; Valproic Acid/pharmacology
    Chemical Substances Antiviral Agents ; IFITM3 protein, human ; Membrane Proteins ; Myxovirus Resistance Proteins ; RNA-Binding Proteins ; Valproic Acid (614OI1Z5WI) ; 2',5'-Oligoadenylate Synthetase (EC 2.7.7.84)
    Keywords covid19
    Language English
    Publishing date 2020-06-10
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.01372
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells

    Hachim, Mahmood Yaseen / Al Heialy, Saba / Hachim, Ibrahim Yaseen / Halwani, Rabih / Senok, Abiola C. / Maghazachi, Azzam A. / Hamid, Qutayba

    Frontiers in Immunology

    2020  Volume 11

    Keywords covid19
    Publisher Frontiers Media SA
    Publishing country ch
    Document type Article ; Online
    ZDB-ID 2606827-8
    ISSN 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.01372
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells

    Hachim, Mahmood Yaseen / Al Heialy, Saba / Hachim, Ibrahim Yaseen / Halwani, Rabih / Senok, Abiola C / Maghazachi, Azzam A / Hamid, Qutayba

    Front Immunol

    Abstract: ... therapeutic interventions. We analyzed publicly available transcriptomic datasets of SARS-CoV infected humans ... infected epithelial cells transcriptomic datasets. Comprehensive toxicogenomic analysis of the identified ... Despite ongoing research toward the development of a vaccine against SARS-CoV-2, such a vaccine will not ...

    Abstract Current guidelines for COVID-19 management recommend the utilization of various repurposed drugs. Despite ongoing research toward the development of a vaccine against SARS-CoV-2, such a vaccine will not be available in time to contribute to the containment of the ongoing pandemic. Therefore, there is an urgent need to develop a framework for the rapid identification of novel targets for diagnostic and therapeutic interventions. We analyzed publicly available transcriptomic datasets of SARS-CoV infected humans and mammals to identify consistent differentially expressed genes then validated in SARS-CoV-2 infected epithelial cells transcriptomic datasets. Comprehensive toxicogenomic analysis of the identified genes to identify possible interactions with clinically proven drugs was carried out. We identified IFITM3 as an early upregulated gene, and valproic acid was found to enhance its mRNA expression as well as induce its antiviral action. These findings indicate that analysis of publicly available transcriptomic and toxicogenomic data represents a rapid approach for the identification of novel targets and molecules that can modify the action of such targets during the early phases of emerging infections like COVID-19.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #619471
    Database COVID19

    Kategorien

  4. Article ; Online: Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells

    Mahmood Yaseen Hachim / Saba Al Heialy / Ibrahim Yaseen Hachim / Rabih Halwani / Abiola C. Senok / Azzam A. Maghazachi / Qutayba Hamid

    Frontiers in Immunology, Vol

    2020  Volume 11

    Abstract: ... therapeutic interventions. We analyzed publicly available transcriptomic datasets of SARS-CoV infected humans ... infected epithelial cells transcriptomic datasets. Comprehensive toxicogenomic analysis of the identified ... Despite ongoing research toward the development of a vaccine against SARS-CoV-2, such a vaccine will not ...

    Abstract Current guidelines for COVID-19 management recommend the utilization of various repurposed drugs. Despite ongoing research toward the development of a vaccine against SARS-CoV-2, such a vaccine will not be available in time to contribute to the containment of the ongoing pandemic. Therefore, there is an urgent need to develop a framework for the rapid identification of novel targets for diagnostic and therapeutic interventions. We analyzed publicly available transcriptomic datasets of SARS-CoV infected humans and mammals to identify consistent differentially expressed genes then validated in SARS-CoV-2 infected epithelial cells transcriptomic datasets. Comprehensive toxicogenomic analysis of the identified genes to identify possible interactions with clinically proven drugs was carried out. We identified IFITM3 as an early upregulated gene, and valproic acid was found to enhance its mRNA expression as well as induce its antiviral action. These findings indicate that analysis of publicly available transcriptomic and toxicogenomic data represents a rapid approach for the identification of novel targets and molecules that can modify the action of such targets during the early phases of emerging infections like COVID-19.
    Keywords COVID-19 ; SARS-CoV-2 ; interferon-induced transmembrane proteins ; valproic acid ; antiviral immunity ; Immunologic diseases. Allergy ; RC581-607 ; covid19
    Subject code 570
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top